Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.

Journal of Thoracic Oncology

English

P1.13-05 Integrin Β3 Inhibition Enhances the Antitumor Activity of Alk Inhibitor in Alkrearranged NSCLC

Journal of Thoracic Oncology

English

P3.09-18 Identification of MET Exon 14 Skipping Mutations by FusionPlexTM Solid Tumor Panel

Journal of Thoracic Oncology

English

MA11.07 Expression of LAG-3 and NY-ESO-1 in Tumor Cells Is Promising Biomarker Predicting Durable Clinical Benefit of PD-1 Blockade in Advanced NSCLC

Journal of Thoracic Oncology

English

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

OA09.03 Discussions Between Health Professionals and Smokers About E-Cigarettes: Results From the ITC Policy Evaluation Project

Journal of Thoracic Oncology

English

P1.16-01 Prognostic Variables Associated With Improved Outcomes in Stage III NSCLC Patients Treated With Consolidation Pembrolizumab

Journal of Thoracic Oncology

English

P1.12-19 Clinico-Pathological Characteristics and Treatment Outcome in Small Cell Lung Cancer: A Single Institutional Experience

Journal of Thoracic Oncology

English

P1.13-02 eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P2.01-94 Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.

P1.13-05 Integrin Β3 Inhibition Enhances the Antitumor Activity of Alk Inhibitor in Alkrearranged NSCLC

P3.09-18 Identification of MET Exon 14 Skipping Mutations by FusionPlexTM Solid Tumor Panel

MA11.07 Expression of LAG-3 and NY-ESO-1 in Tumor Cells Is Promising Biomarker Predicting Durable Clinical Benefit of PD-1 Blockade in Advanced NSCLC

P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer

OA09.03 Discussions Between Health Professionals and Smokers About E-Cigarettes: Results From the ITC Policy Evaluation Project

P1.16-01 Prognostic Variables Associated With Improved Outcomes in Stage III NSCLC Patients Treated With Consolidation Pembrolizumab

P1.12-19 Clinico-Pathological Characteristics and Treatment Outcome in Small Cell Lung Cancer: A Single Institutional Experience

P1.13-02 eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients

P2.01-94 Diagnostic Patterns of Non-Small Cell Lung Cancer at Princess Margaret Cancer Centre